Home » Topics » Regulatory

Regulatory
RSS

Iomed enrolls over 300 patients in phase III study for epicondylitis

Feb. 26, 2001

Janssen completes phase III trials of sustained-release formulation of Risperdal

Feb. 26, 2001

Vita-Invest's combination therapy for hypertension completes phase III

Feb. 23, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

Protopic for severe atopic dermatitis launched in U.S.

Feb. 20, 2001

Altace approved in Canada for expanded indication

Feb. 20, 2001

Novartis receives FDA approval for Foradil Aerolizer for asthma maintenance therapy

Feb. 20, 2001

FDA advisory committee recommends approval of injectable ziprasidone

Feb. 16, 2001

New oral formulation of Zomig approved by FDA

Feb. 15, 2001

Intramuscular formulation of Zyprexa clears hurdle on the way to FDA approval

Feb. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...